TrialClinical cancer research : an official journal of the American Association for Cancer Research2018

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

Steven G DuBois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.